MODN 10.81 Model N Inc. Common Stock Stock Charts $MODN

Solid Move or Risky Shift? Goldwin Inc., a well-regarded behemoth in Japan's outdoors market, is shaking things up and joining hands with Centric Software. We're looking at a modernization spree here, folks. The plan? Whip Goldwin's sprawling product data into shape with Centric PLM, a solution that promises a more structured product development approach. Streamlining,...

EcoVadis Silver Badge: Shorr's Green Path Imagine this: Shorr Packaging strutting around with an EcoVadis Silver Badge pinned to its chest for not one, not two, but three years now. That's right, Shorr Packaging's been elbowing its way to the top tier with their sustainability drive, ranked in the 93rd percentile. For those not keeping score, that's top-notch, considering...

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...

Irvine Set for a Rock Revival Talk about a blast from the past! On March 27, 2027, two titans of the rock world, Foreigner and Night Ranger, are set to ignite Irvine like it's the glory days of arena rock all over again. Hosted at the Great Park Live, this show isn't just a concert—it's a full-scale invasion of rock's golden age right into Southern California's heart....

The Long Game in Cardiology There's this long-standing debate in cardiology about whether sticking a metal stent in an artery actually prevents heart attacks or just looks impressive. Well, after chewing on 25 years of data from the COURAGE trial, CU Anschutz researchers led by Dr. Neel Butala have thrown a curveball — these stents might not be as life-saving as many...

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Westhaven Gold Corporate Update VANCOUVER, British Columbia — Westhaven Gold Corp. (TSX-V: WHN) has recently announced a significant transition with the departure of Sean Thompson, the Vice President of Corporate Development & Investor Relations. This change marks a new chapter for the company as it continues to focus on its exploration and development activities....

TerSera Therapeutics made waves back in 2024 when it presented new data on goserelin, a drug that's been a game-changer for managing breast cancer, especially in younger patients. This wasn't just some routine announcement; it dropped at a major oncology symposium focused on quality care. You know how the market loves buzz around innovative treatments, and this one had...

Introduction to the Link Between Corporate Earnings and Stock Valuations The important and significant connection between earnings and stock prices is often a concern for shareholders, analysts, and the economy. Corporate earnings are also known as the bottom line, net income, or profit and reflect a business entity’s financial status over a certain period. While on the...

Financial Overview for Q3 2024 Hyster-Yale, Inc. (NYSE: HY) has reported solid financial results for Q3 2024, showcasing the company's resilience in navigating seasonal fluctuations. Despite the third quarter typically being slower, Hyster-Yale executed well, achieving a cash generation of $70 million from operations. Highlights from Q3 2024 The Q3 2024 financial...

Bringing European Soccer Insight to American Fans Suddenly we're talking soccer in the U.S. in a way that's making heads spin. It ain't like the old days when only a small bunch tuned in. Now, with Fabrizio Romano, the kingpin of transfer tidbits, hopping onboard Time2play, there's a different energy afoot. It's about time American fans get the scoop the Europeans have...